MedWellAI, Inc.: Increased authorized shares of Series B Convertible Preferred Stock from 1,000,000 to 1,500,000 (effective 2026-04-16).
“On April 16, 2026, MedWellAI, Inc. (the “ Company ”) filed a Certificate of Amendment to the Certificate of Designation, Preferences and Rights of Series B Convertible Preferred Stock of the Company (the “ Certificate of Amendment ”) with the Secretary of State of the State of Nevada.”
Governance Changes
MedWellAI, Inc.: The Company filed a Certificate of Amendment to the Certificate of Designation of Series C Preferred Stock, consolidating Series C and Series D Preferred Stock into a single series and amending the rights, preferences, and limitations accordingly (effective 2025-08-01).
“On August 1, 2025, the Company filed a Certificate of Amendment to the Certificate of Designation of Series C Preferred Stock (the “ Certificate of Amendment ”) with the Secretary of State of the State of Nevada.”
Governance Changes
MedWellAI, Inc.: Company name changed to MedwellAI, Inc. via Amendment to Articles of Incorporation (effective 2025-05-30).
“On May 30, 2025, Integrated Ventures, Inc. (the “Company”) received confirmation from the Secretary of State of the State of Nevada of the filing of the Amendment to Articles of Incorporation (the “Amendment to Articles”), which effected the change of the Company’s name to “MedwellAI, Inc.” (the “Name Change”).”
M&A Transactions
MedWellAI, Inc. completed an acquisition involving Healthy Lifestyle USA LLC for $350,000 (closed 2024-08-29).
“(the “Purchase Agreement”), between Medwell, Healthy Lifestyle, and the members (the “Selling Members”) of Healthy Lifestyle. The purchase price for the Membership Interests was $350,000, consisting of $250,000 in cash (the “Cash Payment”) and 97,087 shares of the Company’s common stock (the “Purchase Shares”) with a market value of $100,000. The number of”
“On April 17, 2023, Integrated Ventures, Inc. (the “Company”) received from the Secretary of State of the State of Nevada the filed Certificate of Change Pursuant to NRS 78.209 , which effected a 1-for-125 reverse stock split (the “Reverse Stock Split”) and reduction in the number of shares of Common Stock that the Company is authorized to issue at the same ratio, with such number of authorized shares of Common Stock reduced from 750 million to 6 million”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.